Lv2
176 积分 2025-03-04 加入
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
1个月前
已关闭
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
1个月前
已完结
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
2个月前
已完结
Durable response to an anti-CD25 antibody-drug conjugate and anti-PD-1 antibody in ovarian carcinoma: a case report
2个月前
已完结
Antibody-bottlebrush prodrug conjugates for targeted cancer therapy
4个月前
已完结
Antibody-bottlebrush prodrug conjugates for targeted cancer therapy
4个月前
已完结
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
6个月前
已完结
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
6个月前
已完结
皖公网安备34019202002308
